BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1033 related articles for article (PubMed ID: 18604659)

  • 1. Preparation and characterization of HA-PEG-PCL intelligent core-corona nanoparticles for delivery of doxorubicin.
    Yadav AK; Mishra P; Jain S; Mishra P; Mishra AK; Agrawal GP
    J Drug Target; 2008 Jul; 16(6):464-78. PubMed ID: 18604659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of doxorubicin.
    Yadav AK; Mishra P; Mishra AK; Mishra P; Jain S; Agrawal GP
    Nanomedicine; 2007 Dec; 3(4):246-57. PubMed ID: 18068091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and characterization of hyaluronic acid decorated PLGA nanoparticles for delivery of 5-fluorouracil.
    Yadav AK; Agarwal A; Rai G; Mishra P; Jain S; Mishra AK; Agrawal H; Agrawal GP
    Drug Deliv; 2010 Nov; 17(8):561-72. PubMed ID: 20738221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oridonin-loaded poly(epsilon-caprolactone)-poly(ethylene oxide)-poly(epsilon-caprolactone) copolymer nanoparticles: preparation, characterization, and antitumor activity on mice with transplanted hepatoma.
    Feng N; Wu P; Li Q; Mei Y; Shi S; Yu J; Xu J; Liu Y; Wang Y
    J Drug Target; 2008 Jul; 16(6):479-85. PubMed ID: 18604660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poly(epsilon-caprolactone)/poly(ethylene glycol)/poly(epsilon-caprolactone) nanoparticles: preparation, characterization, and application in doxorubicin delivery.
    Gou M; Zheng X; Men K; Zhang J; Zheng L; Wang X; Luo F; Zhao Y; Zhao X; Wei Y; Qian Z
    J Phys Chem B; 2009 Oct; 113(39):12928-33. PubMed ID: 19736995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of PEG conformation and particle size on the cellular uptake efficiency of nanoparticles with the HepG2 cells.
    Hu Y; Xie J; Tong YW; Wang CH
    J Control Release; 2007 Mar; 118(1):7-17. PubMed ID: 17241684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor activity of monomethoxy poly(ethylene glycol)-poly (ε-caprolactone) micelle-encapsulated doxorubicin against mouse melanoma.
    Zheng L; Gou M; Zhou S; Yi T; Zhong Q; Li Z; He X; Chen X; Zhou L; Wei Y; Qian Z; Zhao X
    Oncol Rep; 2011 Jun; 25(6):1557-64. PubMed ID: 21455590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poly(epsilon-caprolactone)-poly(ethylene glycol)-poly(epsilon-caprolactone) (PCL-PEG-PCL) nanoparticles for honokiol delivery in vitro.
    Gou M; Zheng L; Peng X; Men K; Zheng X; Zeng S; Guo G; Luo F; Zhao X; Chen L; Wei Y; Qian Z
    Int J Pharm; 2009 Jun; 375(1-2):170-6. PubMed ID: 19427143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poly(ethylene glycol)/poly(epsilon-caprolactone) diblock copolymeric nanoparticles for non-viral gene delivery: the role of charge group and molecular weight in particle formation, cytotoxicity and transfection.
    Jang JS; Kim SY; Lee SB; Kim KO; Han JS; Lee YM
    J Control Release; 2006 Jun; 113(2):173-82. PubMed ID: 16750279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gold nanoparticles with a monolayer of doxorubicin-conjugated amphiphilic block copolymer for tumor-targeted drug delivery.
    Prabaharan M; Grailer JJ; Pilla S; Steeber DA; Gong S
    Biomaterials; 2009 Oct; 30(30):6065-75. PubMed ID: 19674777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Superior antitumor efficiency of cisplatin-loaded nanoparticles by intratumoral delivery with decreased tumor metabolism rate.
    Li X; Li R; Qian X; Ding Y; Tu Y; Guo R; Hu Y; Jiang X; Guo W; Liu B
    Eur J Pharm Biopharm; 2008 Nov; 70(3):726-34. PubMed ID: 18634874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poly(ethyleneglycol)-b-poly(ε-caprolactone-co-γ-hydroxyl-ε- caprolactone) bearing pendant hydroxyl groups as nanocarriers for doxorubicin delivery.
    Chang L; Deng L; Wang W; Lv Z; Hu F; Dong A; Zhang J
    Biomacromolecules; 2012 Oct; 13(10):3301-10. PubMed ID: 22931197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poly(ethylene glycol)-poly(ester-carbonate) block copolymers carrying PEG-peptidyl-doxorubicin pendant side chains: synthesis and evaluation as anticancer conjugates.
    Andersson L; Davies J; Duncan R; Ferruti P; Ford J; Kneller S; Mendichi R; Pasut G; Schiavon O; Summerford C; Tirk A; Veronese FM; Vincenzi V; Wu G
    Biomacromolecules; 2005; 6(2):914-26. PubMed ID: 15762660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, self-assembly, and in vitro doxorubicin release behavior of dendron-like/linear/dendron-like poly(epsilon-caprolactone)-b-poly(ethylene glycol)-b-poly(epsilon-caprolactone) triblock copolymers.
    Yang Y; Hua C; Dong CM
    Biomacromolecules; 2009 Aug; 10(8):2310-8. PubMed ID: 19618927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amphiphilic multi-arm-block copolymer conjugated with doxorubicin via pH-sensitive hydrazone bond for tumor-targeted drug delivery.
    Prabaharan M; Grailer JJ; Pilla S; Steeber DA; Gong S
    Biomaterials; 2009 Oct; 30(29):5757-66. PubMed ID: 19643472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving anticancer activity and reducing systemic toxicity of doxorubicin by self-assembled polymeric micelles.
    Gou M; Shi H; Guo G; Men K; Zhang J; Zheng L; Li Z; Luo F; Qian Z; Zhao X; Wei Y
    Nanotechnology; 2011 Mar; 22(9):095102. PubMed ID: 21270494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyaluronic acid coated poly(butyl cyanoacrylate) nanoparticles as anticancer drug carriers.
    He M; Zhao Z; Yin L; Tang C; Yin C
    Int J Pharm; 2009 May; 373(1-2):165-73. PubMed ID: 19429302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polyethylene glycol-complexed cationic liposome for enhanced cellular uptake and anticancer activity.
    Jung SH; Jung SH; Seong H; Cho SH; Jeong KS; Shin BC
    Int J Pharm; 2009 Dec; 382(1-2):254-61. PubMed ID: 19666094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of cell-penetrating peptide-modified MPEG-PCL diblock copolymeric nanoparticles for systemic gene delivery.
    Tanaka K; Kanazawa T; Shibata Y; Suda Y; Fukuda T; Takashima Y; Okada H
    Int J Pharm; 2010 Aug; 396(1-2):229-38. PubMed ID: 20600726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and evaluation of PEG-PCL nanoparticles for local tetradrine delivery.
    Li R; Li X; Xie L; Ding D; Hu Y; Qian X; Yu L; Ding Y; Jiang X; Liu B
    Int J Pharm; 2009 Sep; 379(1):158-66. PubMed ID: 19524653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 52.